NCI   NIH
Mouse Models of Human Cancers Consortium
Search: 
Site Map
Nervous System Cancer Models Site Navigation  
1.0 Nervous System Tumors
1.1 Gliomas
1.2 Diffuse astrocytomas
1.3 Oligodendroglioma and oligo-astrocytoma
1.4 Ependymoma
1.5 Choroid plexus tumors
1.6 Embryonal tumors
1.7 Meningeal tumors
1.8 Tumors of peripheral nerve
1.9 Tables: The WHO classification:
2.0 Molecular Alterations in Tumors of the Nervous System.
2.1 Molecular Alterations Astrocytomas
2.2 Molecular Alterations in Oligodendroglioma
2.3 Molecular Alterations in Familial And Sporadic Medulloblastoma
2.4 Molecular Alterations in Nerve Sheath Tumors.
2.4.1 Neurofibromas
2.4.2 Malignant Peripheral Nerve Sheath Tumors (MPNSTs)
2.4.3 Schwannomas
2.5 Clinical and Molecular Characterization of Choroid Plexus Tumors.
3.0 GEM mouse models for tumors of the nervous system
3.1 Xenograft Models
3.2 Astrocytoma Models
3.3 Oligodendroglioma and Oligo-Astrocytoma
3.4 Medulloblastoma models
3.5 Malignant Peripheral Nerve Sheath Tumor Models
3.6 Choroid Plexus Tumor Models
4.0 Pre-Clinical Therapeutics For GEM Tumors of the Nervous System
5.0 Protocols and Resources
References
Resources  
1. Nervous System Cancer Models Publication (PubMed)  Opens in New Window: 1. Nervous System Cancer Models Publication (PubMed)
2. Brain SPOREs  Opens in New Window: 2. Brain SPOREs
3. Nervous System Cancer Models (MMHCC)  Opens in New Window: 3. Nervous System Cancer Models (MMHCC)
4. Nervous System Cancer Models (MMHCC Repository)  Opens in New Window: 4. Nervous System Cancer Models (MMHCC Repository)
5. Nervous System Cancer Models (MTB)  Opens in New Window: 5. Nervous System Cancer Models (MTB)
6. Nervous System Cancer Metastases Models (MTB)  Opens in New Window: 6. Nervous System Cancer Metastases Models (MTB)
7. Microarray data (GEDP)  Opens in New Window: 7. Microarray data (GEDP)

skip top level navigationHome Mouse Models Experimental Therapeutics Resources MMHCC Communication Bioinformatics Learning Tools  

  Emice  >  Mouse Models  >  Organ Site Models  >  Nervous System Cancer Models :

Nervous System Cancer Models

Organized and edited by William A. Weiss1, and Ken Aldape2, with contributions from Abhijit Guha3, Mark Israel4, David Louis5, Eric C. Holland6, Andrea I. McClatchey7 , Anat O. Stemmer-Rachamimov5,Terry Van Dyke8 and Cynthia Wetmore9.


1Univ of CA, San Francisco, CA
2MD Anderson Cancer Center, Houston TX
3MSc, MD, FRCS(C), FACS Associate Prof. Neurosurgery, Univ. Health Network Toronto, Ontario, Canada
4Norris Cotton Cancer Center, Dartmouth Medical School, Hanover NH
5Molecular Neuro-Oncology Laboratory, CNY6 Massachusetts General Hospital Charlestown, MA
6Dept of Cell Biology, Neurolgical Surger and Neurology, Memorial Sloan Kettering Cancer Center, New York
7 Harvard Medical School
8 UNC Chapel Hill
9 Mayo clinic

Welcome to the MMHCC Web site for Cancers of the Nervous System. As you enter the site you will find an introductory section providing background information on cancers of the nervous system, a general overview of current methods for diagnosis and treatment, descriptions of commonly occurring molecular alterations, existing murine models for many tumors, and a section on preclinical developmental therapeutics.

Overview of Nervous System Tumors

1.1 Gliomas


General comments
Primary nervous system neoplasms are not among the most common tumors, but some of them are among the most lethal. The prognosis for patients with glioblastoma, the most important of the primary brain tumors, remains at approximately 1 year despite aggressive surgery, radio- and chemotherapy. More needs to be understood about these neoplasms in order to design effective therapies. This short overview will focus on classification of nervous system tumors. It is not meant to be an exhaustive, list but rather will highlight selected neoplasms considered most important and relevant to the MMHCC. Additional information on these and other nervous system neoplasms can be obtained in one of several authoritative texts.

The parenchyma of the central nervous system (CNS) is composed primarily of neurons and glia. In turn, the glia is composed of 3 cell types: astrocytes, oligodendrocytes and ependyma. While neoplasms can arise from either the neuronal or glial components of the CNS, the glial tumors (gliomas) are by far more important both in terms of frequency and clinical aggressiveness. The most common gliomas are those derived from astrocytes and oligodendrocytes. From a practical point of view, the most important initial distinction is to separate diffuse from circumscribed gliomas. Diffuse gliomas, which are most common in the hemispheres of adults, cannot be cured by surgical excision. Such tumors are divided histologically into astrocytomas, oligodendrogliomas and oligo-astrocytomas; either of these three subtypes can transform into the most malignant form, glioblastoma. On the other hand, circumscribed gliomas, although also a diverse group, can often be excised in their entirety and thereby cured.

Diffuse cerebral gliomas are graded by histological criteria to provide estimates of their behavior. The WHO divides these tumors into low-grade (grade II), anaplastic (grade III) and glioblastoma (grade IV). Low-grade tumors have a relatively homogeneous appearance on macroscopic examination, often appearing somewhat more tan and soft than the surrounding normal brain. Because of their diffuse nature, the tumor margins are ill defined, merging imperceptibly with the adjacent white and gray matter. Cystic change may occur, but is less common than in circumscribed types of glioma. There may be grossly visible extension along the ventricular walls and into the ventricles, as well as along the pial surface and into the subarachnoid space. Anaplastic gliomas in general display more heterogeneity macroscopically, with darker regions indicating higher cellularity and vascularity. Finally, glioblastoma appears highly heterogeneous, with yellow zones of necrosis and red regions of hemorrhage in most cases. Macroscopic multifocality is not uncommon in glioblastomas, particularly at autopsy, but this almost always represents spread of a single tumor, rather than true multiple primary gliomas. Spread in this fashion along white matter tracts may be prominent. A curious variant of diffuse glioma is gliomatosis cerebri, in which tumor cells infiltrate throughout the central nervous system without forming conspicuous masses.


CONTACT US PRIVACY NOTICE DISCLAIMER ACCESSIBILITY APPLICATION SUPPORT  
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov